Does TADALAFIL Cause Pulmonary embolism? 72 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Pulmonary embolism have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 0.2% of all adverse event reports for TADALAFIL.
72
Reports of Pulmonary embolism with TADALAFIL
0.2%
of all TADALAFIL reports
18
Deaths
52
Hospitalizations
How Dangerous Is Pulmonary embolism From TADALAFIL?
Of the 72 reports, 18 (25.0%) resulted in death, 52 (72.2%) required hospitalization, and 7 (9.7%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which TADALAFIL Alternatives Have Lower Pulmonary embolism Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR